Cargando…

Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells

Detalles Bibliográficos
Autores principales: Zhou, Lei, Sheng, Dandan, Deng, Qiaodan, Wang, Dong, Liu, Suling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154939/
https://www.ncbi.nlm.nih.gov/pubmed/30249304
http://dx.doi.org/10.1186/s40880-018-0327-7
_version_ 1783357792144326656
author Zhou, Lei
Sheng, Dandan
Deng, Qiaodan
Wang, Dong
Liu, Suling
author_facet Zhou, Lei
Sheng, Dandan
Deng, Qiaodan
Wang, Dong
Liu, Suling
author_sort Zhou, Lei
collection PubMed
description
format Online
Article
Text
id pubmed-6154939
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61549392018-09-27 Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells Zhou, Lei Sheng, Dandan Deng, Qiaodan Wang, Dong Liu, Suling Cancer Commun (Lond) Letter to the Editor BioMed Central 2018-09-24 /pmc/articles/PMC6154939/ /pubmed/30249304 http://dx.doi.org/10.1186/s40880-018-0327-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Zhou, Lei
Sheng, Dandan
Deng, Qiaodan
Wang, Dong
Liu, Suling
Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title_full Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title_fullStr Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title_full_unstemmed Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title_short Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
title_sort development of a novel method for rapid cloning of shrna vectors, which successfully knocked down cd44 in mesenchymal triple-negative breast cancer cells
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154939/
https://www.ncbi.nlm.nih.gov/pubmed/30249304
http://dx.doi.org/10.1186/s40880-018-0327-7
work_keys_str_mv AT zhoulei developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells
AT shengdandan developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells
AT dengqiaodan developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells
AT wangdong developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells
AT liusuling developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells